Answer
Kisunla (donanemab) 350 mg concentrate for solution for infusion is diluted with sodium chloride 9 mg/ml (0.9%) solution for injection, using aseptic technique by a qualified healthcare professional.
Sources for this answer
- Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 3Document updated
Sources checked